NCT05210413 2026-01-15
SPARTO
University Hospital, Bordeaux
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT06895733 2025-03-26
Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)
Tianjin Medical University Second Hospital
Phase 1/2 Recruiting
NCT02303028 2022-06-28
TOPAZ
The Hospital for Sick Children
Phase 1/2 Completed
NCT03628131 2018-09-19
Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
Samsung Medical Center
Phase 1/2 Unknown